Wolverine Trading, LLC Intra Cellular Therapies, Inc. Transaction History

Wolverine Trading, LLC

  • $94.2 Billion
  • Q2 2024

A detailed history of Wolverine Trading, LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Wolverine Trading, LLC holds 3,097 shares of ITCI stock, worth $226,452. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,097
Previous 4,517 31.44%
Holding current value
$226,452
Previous $312,000 32.05%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$64.76 - $79.84 $91,959 - $113,372
-1,420 Reduced 31.44%
3,097 $212,000
Q1 2024

May 15, 2024
BUY
$64.37 - $75.65 $290,759 - $341,711
4,517 New
4,517 $312,000
Q1 2023

May 15, 2023
BUY
$43.8 - $56.99 $376,767 - $490,227
8,602 New
8,602 $482,000
Q4 2021

Feb 14, 2022
SELL
$35.2 - $53.42 $93,104 - $141,295
-2,645 Reduced 32.69%
5,445 $284,000
Q3 2021

Nov 12, 2021
SELL
$28.72 - $42.49 $16,255 - $24,049
-566 Reduced 6.54%
8,090 $290,000
Q3 2020

Nov 13, 2020
SELL
$17.61 - $31.86 $64,980 - $117,563
-3,690 Reduced 29.89%
8,656 $221,000
Q2 2020

Aug 13, 2020
SELL
$14.35 - $26.64 $65,852 - $122,250
-4,589 Reduced 27.1%
12,346 $311,000
Q4 2019

Feb 12, 2020
BUY
$7.26 - $38.49 $863 - $4,580
119 Added 0.71%
16,935 $570,000
Q2 2019

Aug 20, 2019
SELL
$10.65 - $14.29 $9,414 - $12,632
-884 Reduced 4.99%
16,816 $218,000
Q1 2019

May 15, 2019
BUY
$10.9 - $14.09 $18,268 - $23,614
1,676 Added 10.46%
17,700 $216,000
Q4 2018

Feb 14, 2019
SELL
$10.36 - $20.96 $192,468 - $389,394
-18,578 Reduced 53.69%
16,024 $181,000
Q3 2018

Nov 14, 2018
BUY
$17.77 - $22.9 $412,850 - $532,035
23,233 Added 204.35%
34,602 $751,000
Q1 2018

May 15, 2018
BUY
$15.16 - $25.49 $15,993 - $26,891
1,055 Added 10.23%
11,369 $239,000
Q4 2017

Feb 14, 2018
BUY
$14.27 - $16.79 $147,180 - $173,172
10,314
10,314 $149,000

Others Institutions Holding ITCI

# of Institutions
400
Shares Held
87.2M
Call Options Held
309K
Put Options Held
302K
View Full List

About Intra-Cellular Therapies, Inc.

ITCI Quotes by TradingView
  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $6.9B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email